Tags: Drug.
Nimotuzumab (BIOMAb EGFR Biocon India; TheraCIM CIMYM Biosciences Canada; Theraloc Oncoscience Europe CIMAher Center of Molecular Immunology Havana Cuba) is a humanized monoclonal antibody used to treat squamous cell carcinomas of the head and neck recurrent or refractory high grade malignant glioma anaplastic astrocytomas glioblastomas and diffuse intrinsic pontine glioma.